A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Weight loss jabs such as Wegovy are “lifelong treatments ... played a key role in the development of liraglutide and semaglutide, two active ingredients in many of the jabs.

GLP-1 receptor agonists (GLP-1RAs), including liraglutide, semaglutide ... facilitates a 20.9 percent weight loss over 72 weeks. These outcomes are primarily due to mechanisms regulating appetite ...